Bg pattern

EBASTINE COMBIX 10 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use EBASTINE COMBIX 10 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el paciente

Ebastina Combix 10 mg comprimidos recubiertos con película EFG

Lea todo el prospecto detenidamente antes de empezar a tomar este medicamento, porque contiene información importante para usted.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si tiene alguna duda, consulte a su médico o farmacéutico.
  • Este medicamento se le ha recetado solamente a usted y no debe dárselo a otras personas, aunque tengan los mismos síntomas que usted, ya que puede perjudicarles.
  • Si experimenta efectos adversos, consulte a su médico o farmacéutico, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.

Contenido del prospecto:

  1. Qué es Ebastina Combix y para qué se utiliza
  2. Qué necesita saber antes de empezar a tomar Ebastina Combix
  3. Cómo tomar Ebastina Combix
  4. Posibles efectos adversos
  5. Conservación de Ebastina Combix
  6. Contenido del envase e información adicional

1. Qué es Ebastina Combix y para qué se utiliza

Ebastina, el componente activo de Ebastina Combix, pertenece a un grupo de fármacos denominados antihistamínicos.

Este medicamento se utiliza en el tratamiento de procesos alérgicos tales como rinitis alérgica estacional o perenne asociada o no a conjuntivitis alérgica (como descargas nasales, picor de nariz, picor de ojos, lagrimeo, ganas de estornudar), urticaria crónica y dermatitis alérgica.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a tomar Ebastina Combix

No tome Ebastina Combix

  • si es alérgico a ebastina o a alguno de los demás componentes de este medicamento (incluidos en la sección 6).

Advertencias y precauciones

Consulte a su médico antes de empezar a tomar Ebastina Combix:

  • Si presenta un cuadro alérgico agudo de urgencia, ya que este medicamento tarda de 1 a 3 horas en hacer efecto.
  • Este medicamento puede interferir con los resultados de las pruebas alérgicas cutáneas, por lo que se aconseja no realizarlas hasta transcurridos 5-7 días desde la interrupción del tratamiento.
  • Puede potenciar los efectos de otros antihistamínicos.
  • En pacientes con insuficiencia hepática leve o moderada no es necesario ajustar la dosis. En pacientes con insuficiencia hepática grave no debe superarse la dosis de 10 mg/día de ebastina.

Niños

Este medicamento no debe ser administrado a niños menores de 6 años.

Toma de Ebastina Combixconotros medicamentos

Informe a su médico o farmacéutico si está tomando, ha tomado recientemente o pudiera tener que tomar cualquier otro medicamento.

Ebastina puede interaccionar con eritromicina (medicamento antibiótico) o ketoconazol (medicamento para el tratamiento de infecciones producidas por hongos).

Toma de Ebastina Combixcon alimentos y bebidas

Los comprimidos pueden administrarse con o sin alimentos.

Embarazo y lactancia

Si está embarazada o en periodo de lactancia, cree que podría estar embarazada o tiene intención de quedarse embarazada, consulte a su médico o farmacéutico antes de utilizar este medicamento.

Embarazo

No existe experiencia en mujeres embarazadas por lo que se recomienda consultar con un médico antes de tomar este medicamento.

Lactancia

Se desconoce si el medicamento pasa a la leche materna por lo que se recomienda consultar con un médico antes de tomar este medicamento.

Conducción y uso de máquinas

En el hombre no se han observado efectos sobre la función psicomotora, ni sobre la capacidad para conducir o utilizar maquinaria, a las dosis terapéuticas recomendadas. No obstante, observe su respuesta a la medicación porque en algunos casos se ha producido somnolencia a las dosis habituales. Si fuera así, absténgase de conducir y manejar maquinaria peligrosa.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. Cómo Ebastina Combix

Siga exactamente las instrucciones de administración de este medicamento indicadas por su médico. En caso de duda, consulte de nuevo a su médico o farmacéutico.

Su médico le indicará la duración de su tratamiento con este medicamento. Recuerde tomar su medicamento.

La dosis normal recomendada en:

  • Adultos y adolescentes mayores de 12 años: 1 comprimido (10 mg de ebastina) una vez al día.
  • Niños entre 6 y 11 años: medio comprimido (5 mg de ebastina) una vez al día. El comprimido se puede partir en dosis iguales.

Los comprimidos de Ebastina Combix son para administración por vía oral. Los comprimidos deben tragarse enteros, sin masticarlos, con ayuda de un vaso de líquido, preferiblemente agua.

Si estima que la acción de este medicamento es demasiado fuerte o débil, comuníqueselo a su médico o farmacéutico.

Si toma más Ebastina Combix del que debe

Consulte inmediatamente a su médico o farmacéutico o acuda a un hospital. El tratamiento de la intoxicación de este medicamento consiste en un lavado gástrico y la administración de la medicación adecuada. Lleve este prospecto con usted.

En caso de sobredosis o ingestión accidental, consulte al Servicio de Información Toxicológica. Teléfono 91 562 04 20, indicando el medicamento y la cantidad ingerida.

Si olvidó tomar Ebastina Combix

No tome una dosis doble para compensar las dosis olvidadas.

Si interrumpe el tratamiento con Ebastina Combix

No suspenda el tratamiento antes de lo indicado por su médico, ya que puede que empeoren sus síntomas.

Si tiene cualquier otra duda sobre el uso de este medicamento, pregunte a su médico o farmacéutico.

4. Posibles efectos adversos

Al igual que todos los medicamentos, este medicamento puede producir efectos adversos, aunque no todas las personas los sufran.

Los efectos adversos descritos en adultos y adolescentes mayores de 12 años son los siguientes:

  • Frecuentes (pueden afectar hasta 1 de cada 10 personas): dolor de cabeza, somnolencia y sequedad de boca.
  • Poco frecuentes (pueden afectar hasta 1 de cada 100 personas): dolor abdominal, molestias en la digestión, sangrado nasal, rinitis, sinusitis, náuseas e insomnio.
  • Frecuencia no conocida (no puede estimarse a partir de los datos disponibles):aumento de peso y aumento del apetito.

En niños menores de 12 años los acontecimientos adversos descritos son los siguientes:

  • Frecuentes (pueden afectar hasta 1 de cada 10 personas): dolor de cabeza, sequedad de boca y somnolencia.
  • Poco frecuentes (pueden afectar hasta 1 de cada 100 personas): aumento del apetito, diarrea, erupciones cutáneas, nerviosismo, desequilibrio afectivo, movilidad excesiva, alteraciones del gusto y cansancio.

Comunicación de efectos adversos

Si experimenta cualquier tipo de efecto adverso, consulte a su médico o farmacéutico, incluso si se trata de posibles efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de medicamentos de Uso Humano: https:// www.notificaram.es. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Ebastina Combixs

Mantener este medicamento fuera de la vista y del alcance de los niños.

No requiere condiciones especiales de conservación.

No utilice este medicamento después de la fecha de caducidad que aparece en el envase después de CAD. La fecha de caducidad es el último día del mes que se indica.

Los medicamentos no se deben tirar por los desagües ni a la basura. Deposite los envases y los medicamentos que no necesita en el punto SIGRE de la farmacia. En caso de duda pregunte a su farmacéutico cómo deshacerse de los envases y de los medicamentos que no necesita. De esta forma ayudará a proteger el medio ambiente.

6. Contenido del envase e información adicional

Composición de Ebastina Combix

  • El principio activo es ebastina. Cada comprimido contiene 10 mg de ebastina.
  • Los demás componentes (excipientes) son:

Nucleo del comprimido:celulosa microcristalina (E460i), macrogolglicéridos de estearoilo, carboximetilalmidón sódico (tipo A) (de patata), estearato de magnesio (E470b).

Recubrimiento: Agua purificada y opadry blanco (hidroximetilpropilcelulosa (E464), polietilenglicol y dióxido de titanio (E171)).

Aspecto del producto y contenido del envase

Comprimidos recubiertos con película, de color blanco, ovalados, biconvexos y con ranura.

Ebastina Combix está disponible en envases de 20 comprimidos.

Titular de la autorización de comercialización y responsable de la fabricación:

Titular de la autorización de comercialización:

Laboratorios Combix, S.L.U.

C/ Badajoz 2, Edificio 2

28223 Pozuelo de Alarcón (Madrid)

España

Responsable de la fabricación:

Generis Farmaceutica, S.A.

Rua Joao de Deus nº 19,

Venda Nova 2700-487 Amadora

Portugal

Fecha de la última revisión de este prospecto: Abril 2019

La información detallada y actualizada de este medicamento está disponible en la página Web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) http://www.aemps.gob.es/

Online doctors for EBASTINE COMBIX 10 mg FILM-COATED TABLETS

Discuss questions about EBASTINE COMBIX 10 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for EBASTINE COMBIX 10 mg FILM-COATED TABLETS?
EBASTINE COMBIX 10 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in EBASTINE COMBIX 10 mg FILM-COATED TABLETS?
The active ingredient in EBASTINE COMBIX 10 mg FILM-COATED TABLETS is ebastine. This information helps identify medicines with the same composition but different brand names.
How much does EBASTINE COMBIX 10 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for EBASTINE COMBIX 10 mg FILM-COATED TABLETS is around 4.4 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures EBASTINE COMBIX 10 mg FILM-COATED TABLETS?
EBASTINE COMBIX 10 mg FILM-COATED TABLETS is manufactured by Laboratorios Combix S.L.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of EBASTINE COMBIX 10 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether EBASTINE COMBIX 10 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to EBASTINE COMBIX 10 mg FILM-COATED TABLETS?
Other medicines with the same active substance (ebastine) include BACTIL 10 mg FILM-COATED TABLETS, BACTIL FLAS 10 mg ORAL LYOPHILIZED, BACTIL FORTE 20 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media